Back to
COMMERCE BANK
CRVS
Showing 7 of 14 quarters
Position history for
COMMERCE BANK's holdings in CORVUS PHARMACEUTICALS INC
No. Commerce Bank exited its CRVS (Corvus Pharmaceuticals) position in Q1 2026. Its Q4 2025 13F listed 20,000 shares worth $154,000. Commerce Bank first reported CRVS in Q4 2022 and held it in 13 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$105,600
Total Shares Change
-20,000
Quarter-by-Quarter History